BHVN - CIK 0001935979
The table below shows Biohaven Ltd.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $635.07M | $795.87M | $373.28M | $437.07M | $181.49M | $98.46M |
| SG&A | $110.31M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $89.24M |
| $62.77M |
| $130.86M |
| $37.41M |
| $16.05M |
| Operating income | -$745.38M | -$885.11M | -$436.05M | -$567.93M | -$218.90M | -$114.51M |
| Income tax | $1.44M | $735.00K | -$1.38M | $438.00K | $1.37M | $0.00 |
| Net income | -$738.82M | -$846.42M | -$408.17M | -$570.28M | -$213.80M | -$118.67M |
| EPS (diluted) | -$6.86 | -$9.28 | -$5.73 | -$12.75 | -$5.43 | -$3.01 |